Your browser doesn't support javascript.
loading
Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial.
Porter, Duncan; van Melckebeke, Jurgen; Dale, James; Messow, C Martina; McConnachie, Alexander; Walker, Andrew; Munro, Robin; McLaren, John; McRorie, Euan; Packham, Jon; Buckley, Christopher D; Harvie, John; Taylor, Peter; Choy, Ernest; Pitzalis, Costantino; McInnes, Iain B.
Afiliación
  • Porter D; University of Glasgow, Glasgow, UK. Electronic address: duncan.porter@glasgow.ac.uk.
  • van Melckebeke J; University of Glasgow, Glasgow, UK.
  • Dale J; Wishaw General Hospital, Wishaw, UK.
  • Messow CM; Robertson Centre for Biostatistics, Institute of Health and Wellbeing, Glasgow, UK.
  • McConnachie A; Robertson Centre for Biostatistics, Institute of Health and Wellbeing, Glasgow, UK.
  • Walker A; University of Glasgow, Glasgow, UK.
  • Munro R; Wishaw General Hospital, Wishaw, UK.
  • McLaren J; Whytemans Brae Hospital, Fife, UK.
  • McRorie E; Western General Hospital, Edinburgh, UK.
  • Packham J; Haywood Hospital, Stoke-on-Trent, UK.
  • Buckley CD; University of Birmingham, Birmingham, UK.
  • Harvie J; Raigmore Hospital, Inverness, UK.
  • Taylor P; University of Oxford, Oxford, UK.
  • Choy E; University of Cardiff, Cardiff, UK.
  • Pitzalis C; Queen Mary University, London, UK.
  • McInnes IB; University of Glasgow, Glasgow, UK.
Lancet ; 388(10041): 239-47, 2016 Jul 16.
Article en En | MEDLINE | ID: mdl-27197690

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Reumatoide / Factor de Necrosis Tumoral alfa / Antirreumáticos / Rituximab Tipo de estudio: Clinical_trials / Guideline Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Reumatoide / Factor de Necrosis Tumoral alfa / Antirreumáticos / Rituximab Tipo de estudio: Clinical_trials / Guideline Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2016 Tipo del documento: Article